UBE2V2P2

Across TCGA pan-cancer cohorts, UBE2V2P2 RNA is linked to patient survival in 10 of 34 cancer types, making it the most broadly survival-associated UBE2V2P2 data layer.

The strongest signal is observed in lymphoid neoplasm diffuse large b-cell lymphoma (DLBC), where higher UBE2V2P2 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated UBE2V2P2 expression acts as an unfavorable survival marker, although some lineages such as LUAD and HNSC show a favorable association.

DLBC, THCA, and PAAD are the cancer types where UBE2V2P2 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
DLBC	OS	Tertile	II,III,IV	0.172	0.949	<.001	54	view →
THCA	OS	Tertile	III,IV	0.455	0.809	<.001	45	view →
PAAD	DFS	Tertile	All	0.292	0.496	.011	36	view →
UVM	OS	Tertile	All	0.248	0.769	.007	18	view →
LUAD	DFS	Tertile	All	0.810	0.650	.030	18	view →
ACC	OS	Tertile	III,IV	0.258	0.612	.045	18	view →
HNSC	OS	Tertile	All	0.898	0.742	.023	12	view →
SKCM	DFS	Tertile	II,III,IV	0.457	0.723	.012	9	view →
KIRC	DFS	Tertile	II,III,IV	0.824	0.451	.048	6	view →
STAD	DFS	Median	III,IV	0.395	0.564	.048	1	view →

Pink = unfavorable, green = favorable. Showing the 10 strongest of 10 lineages.

UBE2V2P2–DLBC (OS)

Open the DLBC breakdown →